![]() ![]() The initial diagnosis is based on a history of ingestion ofĮven a few grams of acrylamide crystal. Signs and symptoms of motor and sensory peripheral Chronic Occupational exposureĮxcessive sweating, especially of extremities. 2.2 Summary of clinical effects Acute ingestionĭelayed peripheral neuropathy. Toxic effect depends on the duration of exposure and the SUMMARY 2.1 Main risks and target organs Acrylamide is a potent neurotoxin affecting both theĬentral and peripheral nervous systems. Production facility: Garyville, LA 70051. Production facility: Main Street, Midland, MI ![]() Headquarters: 2020 Dow Center, Midland, MI Production facilities: Avondale, LA 70094.īotlek, The Netherlands. Headquarters: 1 Cyanamid Plaza, Wayne, NJ RTECS registry number: AS 33250000 1.5 Main brand names, main trade names USA: AAM Optimum Amresco Acryl-40 Optimum Acrylage 1 1.6 Main manufacturers, main importers American Cyanamid Company 1.4 Identification numbers 1.4.1 CAS number NAME 1.1 Substance Acrylamide 1.2 Group Amide 1.3 Synonyms 2-Propenamide Acrylic acid amide Acrylic amide Acrylamide monomer Akrylamid Ethylene carboxamide Propenamide Propeneamide Propenoic acid amide. International Programme on Chemical Safetyġ. AUTHOR(S), REVIEWER(S), ADDRESS(ES), DATE(S) (INCLUDING UPDATES) ![]() TOXICOLOGICAL ANALYSES & BIOMEDICAL INVESTIGATIONSĨ.1.2 Storage of laboratory samples and specimensĨ.1.3 Transport of laboratory samples and specimensĨ.2 Toxicological Analyses and Their InterpretationĨ.2.1 Tests on toxic ingredient(s) of materialĨ.2.1.2 Advanced qualitative confirmation test(s)Ĩ.2.2.2 Advanced qualitative confirmation test(s)Ĩ.2.3 Interpretation of toxicological analysesĨ.3 Biomedical investigations and their interpretationĨ.3.4 Interpretation of biomedical investigationsĨ.4 Other biomedical (diagnostic) investigations and their interpretationĨ.5 Overall interpretation of all toxicological analyses and toxicological investigationsĩ.4 Systematic description of clinical effectsĩ.4.9 Eye, ears, nose, throat: local effectsĩ.4.12.2 Fluid & electrolyte disturbancesġ4. 2.4 First-aid measures and management principlesĦ.3 Biological half-life by route of exposureħ.2.5 Acceptable daily intake (ADI) and other guideline levelsĨ. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |